21-(ACETYLOXY)-6,9-DIFLUORO-11-HYDROXYPREGNA-1,4,16-TRIENE-3,20-DIONE, (6.ALPHA.,11.BETA.)-
UNII B3QNX9A6DQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 21-(acetyloxy)-6,9-difluoro-11-hydroxypregna-1,4,16-triene-3,20-dione, (6.alpha.,11.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B3QNX9A6DQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2326-26-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H26F2O5 YXASFOVLXBFEEU-LKVAYOKUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 21-(acetyloxy)-6,9-difluoro-11-hydroxypregna-1,4,16-triene-3,20-dione, (6.alpha.,11.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.